Year: 2009
Type: article
Abstract: From the point of view of genome medicine, Barack Obama has made two vital policy decisions: he has chosen a new director of the National Institutes of Health, and his proposed change in United States healthcare policy will have profound effects on genome medicine and, indeed, all of academic medicine.
Source: Genome Medicine
DOI: 10.1186/gm86
Authors: David G Nathan, Stuart H Orkin
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,290
OpenAlex ID: W2078128456
